Contract radiopharmaceutical CDMO with 45+ U.S. and international facilities
PharmaLogic operates a distributed network of radiopharmaceutical manufacturing and distribution sites across the U.S., Puerto Rico, Canada, and Norway. The hiring velocity is accelerating with 70 open roles (46 posted in the last 30 days), heavily skewed toward healthcare and manufacturing staff—a classic brownfield manufacturing expansion pattern. Active projects center on FDA compliance, quality control, and operational consolidation, while pain points cluster around cGMP/NRC regulatory requirements, cost control, and equipment reliability—the hallmark friction points of a scaling contract manufacturer handling controlled substances.
PharmaLogic is a contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. The company operates a network of more than 45 facilities across the U.S., Puerto Rico, Canada, and Norway, serving clinical and commercial-stage programs in oncology, cardiology, and Alzheimer's disease diagnostics. PharmaLogic manufactures and distributes commercial radiopharmaceutical therapeutics across more than 30 countries and is the only cGMP-compliant CDMO currently bringing commercial radiopharmaceutical therapeutics to market. The organization delivers end-to-end solutions spanning product development, manufacturing, quality assurance, and logistics, operating under stringent FDA and NRC regulatory frameworks.
PharmaLogic uses GCP and Azure Entra ID for cloud and identity management, Microsoft 365 ecosystem (Teams, SharePoint, Exchange, OneDrive) for collaboration, Power Platform (Apps, Automate, BI) for business automation, and analytical instruments (HPLC, ICP-MS, ICP-OES) for quality control and testing.
PharmaLogic operates a network of more than 45 facilities across the U.S., Puerto Rico, Canada, and Norway, supporting diagnostic and therapeutic radiopharmaceutical manufacturing and distribution.
Other companies in the same industry, closest in size